Apertura Gene Therapy and Rett Syndrome Research Trust Collaborate to Pioneer Advanced Genetic Medicines for Rett Syndrome Using TfR1-Targeted AAV Capsid
NEW YORK and TRUMBULL, Conn., April 30, 2025 /PRNewswire/ -- Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy...

CDC in Nigeria | Global Health
Global Health Updates: US & WHO News
Unlocking the Potential of Gene Therapy for Genetic Skin Disorders